C
VKTX icon

Covestor’s Viking Therapeutics VKTX Stock Holding History

Covestor’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Sell
236
-188
-44% -$6.04K 0.01% 1623
2025
Q4 		$15K Hold
424
– – 0.01% 1412
2025
Q3 		$11K Sell
424
-1
-0.2% -$30 0.01% 1575
2025
Q2 		$11K Sell
425
-829
-66% -$21.8K 0.01% 1567
2025
Q1 		$30K Buy
1,254
+1,094
+684% +$34.6K 0.02% 1048
2024
Q4 		$6K Buy
160
+2
+1% +$114 ﹤0.01% 1703
2024
Q3 		$10K Buy
158
+1
+0.6% +$59 0.01% 1590
2024
Q2 		$8K Buy
157
+153
+3,825% +$10K 0.01% 1695
2024
Q1 		$0 Sell
4
-4
-50% -$178 ﹤0.01% 2811
2023
Q4 		$0 Sell
8
-1
-11% -$13 ﹤0.01% 2798
2023
Q3 		$0 Buy
+9
New +$129 ﹤0.01% 2791

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return